|
CN100389827C
(zh)
|
1996-09-30 |
2008-05-28 |
阿肯萨斯大学 |
用于主动免疫的疫苗制剂，其应用和制备方法
|
|
JP3990736B2
(ja)
*
|
1997-08-21 |
2007-10-17 |
タカラバイオ株式会社 |
制がん剤
|
|
DK1829551T3
(da)
*
|
1998-02-20 |
2011-01-24 |
Univ Miami |
Modificeret varmchokprotein-antigenpeptid-kompleks
|
|
ATE428441T1
(de)
*
|
1998-05-26 |
2009-05-15 |
Genitrix Llc |
Zusammensetzungen und verfahren zur modulation einer immunantwort auf ein antigen durch verabreichung von zytokine-beladenen zellen
|
|
US7030211B1
(en)
*
|
1998-07-08 |
2006-04-18 |
Gemvax As |
Antigenic peptides derived from telomerase
|
|
US6884785B2
(en)
*
|
1999-06-17 |
2005-04-26 |
The Scripps Research Institute |
Compositions and methods for the treatment or prevention of autoimmune diabetes
|
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
GB9930591D0
(en)
*
|
1999-12-23 |
2000-02-16 |
Univ London |
Component for vaccine
|
|
AU2001278117A1
(en)
*
|
2000-08-03 |
2002-02-18 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
WO2002041913A1
(en)
*
|
2000-11-27 |
2002-05-30 |
Jens Christian Jensenius |
Collectins as adjuvants
|
|
US7507724B2
(en)
|
2001-01-16 |
2009-03-24 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
|
AU2002350409A1
(en)
*
|
2001-10-26 |
2003-05-06 |
Uffe Holmskov |
Surfactant protein-d and atherosclerosis
|
|
CA2492160A1
(en)
*
|
2002-07-12 |
2004-01-22 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US20090110702A1
(en)
*
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
|
AU2003262650B2
(en)
|
2002-08-14 |
2009-10-29 |
Macrogenics, Inc. |
FcgammaRIIB-specific antibodies and methods of use thereof
|
|
BR0313650A
(pt)
*
|
2002-08-20 |
2007-08-14 |
Genitrix Llc |
composição, vetor de expressão, composição de vacina e uso
|
|
US20040091503A1
(en)
*
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
US7691393B2
(en)
*
|
2003-02-06 |
2010-04-06 |
Anza Therapeutics, Inc. |
Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
|
|
AU2004224425B2
(en)
*
|
2003-02-06 |
2010-06-24 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
US7695725B2
(en)
*
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
US9701725B2
(en)
*
|
2003-05-05 |
2017-07-11 |
The Johns Hopkins University |
Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
GB0315991D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Dakocytomation Denmark As |
Standard
|
|
US7842289B2
(en)
*
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
AU2005322960A1
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines
|
|
WO2006081323A2
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
US20060188526A1
(en)
*
|
2005-02-24 |
2006-08-24 |
Cunnion Kenji M |
Method for enhancing the immune response to Staphylococcus aureus infection
|
|
EP2119450B1
(en)
|
2005-11-29 |
2013-02-13 |
Actogenix N.V. |
Induction of mucosal tolerance to pancreatic islet beta-cell autoantigens
|
|
US8067237B2
(en)
|
2005-12-13 |
2011-11-29 |
President And Fellows Of Harvard College |
Scaffolds for cell transplantation
|
|
WO2007084661A2
(en)
*
|
2006-01-17 |
2007-07-26 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
|
JP2009536951A
(ja)
*
|
2006-05-12 |
2009-10-22 |
オクラホマ メディカル リサーチ ファウンデーション |
炭疽菌組成物ならびに使用および生成方法
|
|
HUE030269T2
(en)
|
2006-06-26 |
2017-04-28 |
Macrogenics Inc |
FC RIIB-specific antibodies and methods for their use
|
|
WO2008024844A2
(en)
*
|
2006-08-22 |
2008-02-28 |
The Johns Hopkins University |
Anticancer combination therapies
|
|
EP2125010B1
(en)
|
2007-01-25 |
2014-06-04 |
Actogenix N.V. |
Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
|
WO2009039125A1
(en)
*
|
2007-09-17 |
2009-03-26 |
The Schepens Eye Research Institute, Inc. |
Use of ocular neuropeptides as immune adjuvants
|
|
EP2254602B1
(en)
|
2008-02-13 |
2018-11-21 |
President and Fellows of Harvard College |
Continuous cell programming devices
|
|
US8475785B2
(en)
|
2008-03-03 |
2013-07-02 |
The University Of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
EP2274001A4
(en)
|
2008-03-20 |
2012-08-01 |
Univ Miami |
VACCINATION WITH HEAT SHOCK PROTEIN GP96 AND APPLICATION METHOD THEREFOR
|
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
|
IN2012DN06589A
(enExample)
|
2010-01-19 |
2015-10-23 |
Harvard College |
|
|
CA2813751C
(en)
|
2010-10-06 |
2019-11-12 |
President And Fellows Of Harvard College |
Injectable, pore-forming hydrogels for materials-based cell therapies
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
CA3149018A1
(en)
|
2011-07-18 |
2013-01-24 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
|
JP6219832B2
(ja)
|
2011-10-17 |
2017-10-25 |
マサチューセッツ インスティテュート オブ テクノロジー |
細胞内送達
|
|
CA2865744A1
(en)
|
2012-02-29 |
2013-09-06 |
President And Fellows Of Harvard College |
Rapid antibiotic susceptibility testing
|
|
CN107137357B
(zh)
|
2012-04-16 |
2020-11-24 |
哈佛学院董事会 |
用于调节免疫反应的介孔二氧化硅组合物
|
|
EP2674167A1
(en)
*
|
2012-06-14 |
2013-12-18 |
PLS-Design GmbH |
Controlled activation of complement components for use as endogenous adjuvant
|
|
EP2976642A4
(en)
|
2013-03-15 |
2016-09-21 |
Harvard College |
METHOD AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR RECORDING OF A TARGET UNIT
|
|
WO2014190040A1
(en)
|
2013-05-21 |
2014-11-27 |
President And Fellows Of Harvard College |
Engineered heme-binding compositions and uses thereof
|
|
SG11201601927SA
(en)
|
2013-08-16 |
2016-04-28 |
Massachusetts Inst Technology |
Selective delivery of material to cells
|
|
WO2015095604A2
(en)
|
2013-12-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Methods and assays relating to circulating tumor cells
|
|
US10682400B2
(en)
|
2014-04-30 |
2020-06-16 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
CN107109362A
(zh)
|
2014-10-31 |
2017-08-29 |
麻省理工学院 |
递送生物分子至免疫细胞
|
|
CA2964138C
(en)
|
2014-11-14 |
2023-11-14 |
Massachusetts Institute Of Technology |
Disruption and field enabled delivery of compounds and compositions into cells
|
|
CN107250373A
(zh)
|
2015-01-12 |
2017-10-13 |
麻省理工学院 |
通过微流体递送实现的基因编辑
|
|
WO2016123573A1
(en)
|
2015-01-30 |
2016-08-04 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
|
JP6744318B2
(ja)
|
2015-02-06 |
2020-08-26 |
ヒート バイオロジクス，インコーポレイテッド |
ワクチンおよび共刺激分子を共発現するベクター
|
|
EP3280464A4
(en)
|
2015-04-10 |
2018-09-26 |
President and Fellows of Harvard College |
Immune cell trapping devices and methods for making and using the same
|
|
WO2017008063A1
(en)
|
2015-07-09 |
2017-01-12 |
Massachusetts Institute Of Technology |
Delivery of materials to anucleate cells
|
|
CN108289928B
(zh)
|
2015-08-06 |
2024-09-17 |
哈佛大学校长及研究员协会 |
改进的微生物-结合分子和其用途
|
|
EP3344575B1
(en)
|
2015-09-04 |
2020-04-15 |
SQZ Biotechnologies Company |
Intracellular delivery of biomolecules to cells comprising a cell wall
|
|
CN115487351A
(zh)
|
2016-02-06 |
2022-12-20 |
哈佛学院校长同事会 |
重塑造血巢以重建免疫
|
|
WO2017143024A2
(en)
|
2016-02-16 |
2017-08-24 |
President And Fellows Of Harvard College |
Pathogen vaccines and methods of producing and using the same
|
|
DK3484448T3
(da)
|
2016-07-13 |
2025-06-10 |
Harvard College |
Antigenpræsenterende cellemimetiske stilladser og fremgangsmåder til fremstilling og brug af disse
|
|
JP7274214B2
(ja)
|
2016-08-02 |
2023-05-16 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
免疫応答を調節するための生体材料
|
|
US11666649B2
(en)
|
2016-10-11 |
2023-06-06 |
University Of Miami |
Vectors and vaccine cells for immunity against Zika virus
|
|
CA3058938A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
US20200262879A1
(en)
|
2017-09-11 |
2020-08-20 |
Insideoutbio, Inc. |
Methods and compositions to enhance the immunogenicity of tumors
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
US20210403519A1
(en)
|
2018-11-02 |
2021-12-30 |
Insideoutbio, Inc. |
Methods and compositions to induce or suppress immune responses through the use of membrane bound complement split products
|